BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0120
+0.0020 (20.00%)
Jan 20, 2026, 9:30 AM EST
BioRegenx Revenue
BioRegenx had revenue of $507.75K in the quarter ending September 30, 2025, a decrease of -14.81%. This brings the company's revenue in the last twelve months to $1.93M, down -24.56% year-over-year. In the year 2024, BioRegenx had annual revenue of $2.34M, down -31.40%.
Revenue (ttm)
1.93M
Revenue Growth
-24.56%
P/S Ratio
6.98
Revenue / Employee
385.87K
Employees
5
Market Cap
13.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.34M | -1.07M | -31.40% |
| Dec 31, 2023 | 3.41M | 3.37M | 7,991.78% |
| Dec 31, 2022 | 42.16K | -3.95M | -98.94% |
| Dec 31, 2021 | 3.99M | -3.80M | -48.79% |
| Dec 31, 2020 | 7.79M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vaso Corporation | 89.11M |
| Veri Medtech Holdings | 11.89M |
| Pharma-Bio Serv | 9.18M |
| CareView Communications | 8.82M |
| DATATRAK International | 6.50M |
| CompuMed | 1.69M |
| Resilient Healthcare | 1.21M |
| Dogecoin Cash | 721.56K |
BioRegenx News
- 9 months ago - BioRegenx, Inc. Engages Sichenzia Ross Ference Carmel LLP for Legal Representation in Connection with Planned Uplisting to National Stock Exchange - Accesswire